Cervical cancer and human papillomavirus

Balkan Journal of Medical Genetics

Volumn 8, Issue 1-2, 2005, Pages 19-25

  Grce, Magdalena ^a  

^a RUDER BO KOVI INSTITUTE   (Croatia)

Author keywords

Cervical cancer; Human papillomavirus (HPV); Screening

Indexed keywords

VIRUS VACCINE;

CANCER INVASION; CANCER MORTALITY; CANCER PREVENTION; CANCER SCREENING; CAUSE OF DEATH; CLINICAL TRIAL; CYTOLOGY; EARLY DIAGNOSIS; HUMAN; REVIEW; UTERINE CERVIX CANCER; VIRUS CARCINOGENESIS; VIRUS EXAMINATION; VIRUS INFECTION; WART VIRUS;

CANCER VIRUS; HUMAN PAPILLOMAVIRUS; HUMAN PAPILLOMAVIRUS TYPES;

EID: 26644442773     PISSN: 13110160     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (27)

1. IARC (International Agency for Research on Cancer). Monograph on the evaluation of carcinogenic risks to humans, Vol 64. Human papillomaviruses. Lyon: IARC, 1995.
2. Ferlay J, Bray F, Pisani P, Parkin DM. Globocan 2002: cancer incidence, mortality and prevalence worldwide. IARC Cancer Base No. 5. Version 2.0. Lyon: IARC Press, 2004.
3. Bethesda Workshop. The 1988 Bethesda system for reporting cervical/vaginal cytological diagnosis: report of the National Cancer Institute, Bethesda. JAMA 1989; 262(7): 931-934.
4. de Villiers EM. Human pathogenic papillomavirus types: an update. Curr Topics Microbiol Immunol 1994; 186: 1-12.
5. Walboomers JMM, Jacobs MV, Manos MM, Bosch FX, Kummer JA, Shah KV, Snijders PJF, Peto J, Meijer CJLM, Munoz N. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 1999; 189(1): 12-19.
6. Munoz N, Bosch FX, de Sanjose S, Herrero R, Castellsague X, Shah KV, Snijders PJF, Meijer CJLM. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med 2003; 384(6): 518-527.
7. Chan SY, Delius H, Halpern AL, Bernard HU. Analysis of genomic sequences of 95 papillomavirus types: uniting typing, phylogeny, and taxonomy. J Virol 1995; 69(5): 3074-3083.
8. Bosch FX, Lorincz A, Munoz N, Meijer CJLM, Shah KV. The causal relation between human papillomavirus and cervical cancer. J Clin Pathol 2002; 55(4): 244-265.
9. Grce M, Husnjak K, Bozikov J, Zlacki M, Lukac J, Fistonic I, Magdic L, Skrablin S, Sikanic-Dugic N, Pavelic K. Cervical human papillomavirus (HPV) infections in Croatia. Anticancer Res 2001; 21(1B): 579-584.
10. Clifford GM, Smith, Aguado T, Franceschi S. Comparison of HPV type distribution in high-grade cervical lesions and cervical cancer: a meta-analysis. Br J Cancer 2003; 89(1): 101-105.
11. zur Hausen H. Molecular pathogenesis of cancer of the cervix and its causation by specific human papillomavirus types. Curr Topics Microbiol Immunol 1994; 186: 131-155.
12. Kim NW. Clinical implications of telomerase in cancer. Eur J Cancer 1997; 33(5): 781-786.
13. Moreno V, Bosch FX, Munoz N, Meijer CJ, Shah KV, Walboomers JM, Herrero R, Franceschi S; International Agency for Research on Cancer. Multicentric Cervical Cancer Study Group. Effect of oral contraceptives on risk of cervical cancer in women with human papillomavirus infection: the IARC multicentric case-control study. The Lancet 2002; 359(9312): 1085-1092.
14. Smith JS, Green J, Berrington de Gonzalez A, Appleby P, Peto J, Plummer M, Franceschi S, Beral V. Cervical cancer and use of hormonal contraceptives: a systematic review. The Lancet 2003; 361(9364): 1159-1167.
15. Plummer M, Herrero R, Franceschi S, Meijer CJ, Snijders P, Bosch FX, de Sanjose S, Munoz N. Smoking and cervical cancer: pooled analysis of the IARC multi-centric case-control study. Cancer Causes Control 2003; 14(9): 805-814.
16. Castellsague X, Bosch FX, Munoz N, Meijer CJ, Shah KV, de Sanjose S, Eluf-Neto J, Ngelangel CA, Chichareon S, Smith JS, Herrero R, Moreno V, Franceschi S, IARC Multicenter Cervical Cancer Study Group. Male circumcision, penile human papillomavirus infection, and cervical cancer in female partners. N Engl J Med 2002; 346(15): 1105-1112.
17. Holmes KK, Levine R, Weaver M. Effectiveness of condoms in preventing sexually transmitted infections. Bull World Health Organ 2004; 82(6): 454-461.
18. Fahey MT, Irwig L, Macaskill P. Meta-analysis of Pap test accuracy. Am J Epidemiol 1995; 141(7): 680-689.
19. Sherman ME. Future directions in cervical pathology. J Natl Cancer Inst Monogr 2003; 31: 72-79.
20. Cuzick J. Role of HPV testing in clinical practice. Virus Res 2002; 89(2): 263-269.
21. Monsonego J, Bosch FX, Coursaget P, Cox JT, Franco E, Frazer I, Sankaranarayanan R, Schiller J, Singer A, Wright TC Jr, Kinney W, Meijer CJ, Linder J, McGoogan E, Meijer C. Cervical cancer control, priorities and new directions. Int J Cancer 2004; 108(3): 329-333.
22. Wright TC Jr, Cox JT, Massad LS, Twiggs LB, Wilkinson EJ, for the 2001 ASCCP-Sponsored Consensus Conference. 2001 Consensus guidelines for the management of women with cervical cytological abnormalities. JAMA 2002; 287(16): 2120-2129.
23. Ljubojevic N, Babic S, Audy-Jurkovic S, Ovanin-Rakic A, Jukic S, Babic D, Grubisic G, Radakovic B, Ljubojevic-Grgec D. Improved national Croatian diagnostic and therapeutic guidelines for premalignant lesions of the uterine cervix with some cost-benefit aspects. Coll Antropol 2001; 25(2): 467-474.
24. Husnjak K, Grce M, Magdic L, Pavelic K. Comparison of five different polymerase chain reaction (PCR) methods for detection of human papillomavirus (HPV) in cervical cell specimens. J Virol Methods 2000; 88(2): 125-134.
25. Iftner T, Villa LL. Human papillomavirus technologies. J Natl Cancer Inst Monogr 2003; 31: 80-88.
26. Cohen S. Beyond slogans: lessons from Uganda's experience with ABC and HIV/AIDS. Reprod Health Matters 2004; 12(23): 132-135.
27. Koutsky LA, Ault KA, Wheeler CM, Brown DR, Barr E, Alvarez FB, Chiacchierini LM, Jansen KU. A controlled trial of a human papillomavirus type 16 vaccine. N Engl J Med 2002; 347(21): 1645-1651.